These observations in mice and nonhuman primates may be analogous to the Parkinson's Progression Marker Initiative (PPMI) showing higher DAT in as yet-unaffected mutant GBA carriers—prior to the onset of clinical parkinsonism [224]. Here, SLC6A3 is linked to Parkinson disease.